Axogen Overview

  • Founded
  • 2002
  • Status
  • Public
  • Employees
  • 355
  • Stock Symbol
  • AXGN
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $18.41
  • (As of Tuesday Closing)

Axogen General Information


Axogen Inc is a medical technology company. It provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. The firm's product portfolio includes Avance nerve graft, Axoguard nerve connector and nerve protector, Avive soft tissue membrane, Axotouch two-point membrane, and Acroval Neurosensory and motor testing system.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Drug Discovery
Therapeutic Devices
Stock Exchange
Primary Office
  • 13631 Progress Boulevard
  • Suite 400
  • Alachua, FL 32615
  • United States
+1 (888) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Axogen Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$18.41 $18.74 $7.16 - $20.83 $748M 40.6M 241K -$0.63

Axogen Financials Summary

In Thousands,
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 400,363 609,801 663,792 971,926
Revenue 107,967 106,712 83,937 60,426
EBITDA (21,156) (26,218) (20,338) (7,415)
Net Income (24,814) (29,135) (22,397) (10,445)
Total Assets 193,937 154,643 160,173 58,875
Total Debt 53,292 3,331 63 24,545
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Axogen Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Axogen‘s full profile, request access.

Request a free trial

Axogen Executive Team (17)

Name Title Board Seat Contact Info
Karen Zaderej Chief Executive Officer & Chairman
Peter Mariani Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Isabelle Billet Executive & Chief Strategy Officer, Strategy
Brad Ottinger General Counsel, Legal & Chief Compliance Officer, Legal
Gregory Freitag JD Board Member & Executive
You’re viewing 5 of 17 executive team members. Get the full list »

Axogen Board Members (15)

Name Representing Role Since
Amy Wendell Axogen Board Member 000 0000
Gregory Freitag JD Axogen Board Member & Executive 000 0000
Guido Neels EW Healthcare Partners Board Member 000 0000
Karen Zaderej Axogen Chief Executive Officer & Chairman 000 0000
Mark Gold MD Self Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Axogen Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Axogen Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 30-Sep-2011 000000000000000000 0000 Therapeutic Devices 00000 0000000
To view Axogen’s complete acquisitions history, request access »

Axogen Subsidiaries (1)

Company Name Industry Location Founded
000000 Therapeutic Devices Texarkana, TX 0000
To view Axogen’s complete subsidiaries history, request access »